Free Newsletter
Brazilian Dengue outbreak highlights vaccine need
An outbreak of dengue fever in and around Rio de Janeiro has afflicted more than 75,000 people since the beginning of the year, with 12 people dying in just the past week. No vaccine is available for the disease, leaving health officials to house patients in a tent city of the sick as they call in the military to help fumigate areas in an attempt to eradicate the mosquitoes that carry the disease. Rio Governor Sergio Cabral says he may also ask Cuba to help by dispatching doctors to treat the ill.
Hawaii Biotech, meanwhile, has garnered a million dollar grant to move an experimental dengue vaccine into the clinic. Hawaii Biotech's dengue vaccine program has attracted $10 million in grants over the past five years. This latest grant is coming from the Pediatric Dengue Vaccine Initiative of the Seoul-based International Vaccine Institute, which is funded by the Bill and Melinda Gates Foundation.
- check out this report
- read the Star Bulletin article on Hawaii Biotech
Related Articles:
Hawaii Biotech moves West Nile vaccine into clinic
Maxygen, Sanofi Pasteur ink $24.5M Dengue vaccine deal
Comments
If it can help on your research, brazilian people from the northeast part of the country are using "listerine" on their legs, taking B supplements - vitamin - it is said that the mosquitos hate the smell that that complex b comes from our skin so they dont bite those people who take that vitamin. In the back yard not let any stopped water on tires, pans, etc and spread ground coffee and moth balls areound de garden or yeard. And most common still using the mosquitos repelents bought at any supermarket.
- reply
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
SHARE
WITH: